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The addition of ANF to Percoll-purified liver plasma membranes produced a slight activation of guanylate 
cyclase; the ANF-stimulated cyclase activity was further increased upon the addition of ATP to the enzyme 
assay mixture. The effect of ATP to potentiate the cyclase activation was concentration-dependent, required 
MgZ+ as a divalent cation, and was seen with membranes from various tissues and cells. ATP increased 
the maximal velocity of the cyclase without a change in the affinity for GTP or ANF. Phosphorylation by 
ATP might not be involved since ANF-stimulated guanylate cyclase was enhanced by non-phosphorylating 
ATP analogues as well. Thus, an allosteric ATP binding site is suggested to participate in ANF-induced 
regulation of membrane-bound guanylate cyclase. 
Atria1 natriuretic factor; Guanylate cyclase; ATP 
1. INTRODUCTION 
Atria1 natriuretic factor (ANF) secreted from 
cardiac atria increases cellular cGMP probably as 
a result of activation of guanylate cyclase in par- 
ticulate fractions [ 1,2], although the activation of 
enzyme is usually not so marked as the increment 
in the cyclic nucleotide observable in intact cells 
[3-51. We will describe that ATP enhances ANF- 
induced activation of guanylate cyclase in mem- 
branes from various tissues. 
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2. MATERIALS AND METHODS 
2.1. Preparation of liver plasma membranes 
Plasma membranes were prepared from rat liver 
at 0-4°C by the method of Seyfred and Wells [6] 
with slight modifications as follows. Liver tissues 
excised from Donryu rats (body weight 200-300 g) 
were homogenized in 20 mM Hepes (pH 
7.5)/S mM EDTA/250 mM sucrose/aprotinin by 
means of a Polytron homogenizer (PT 
10-20-3500). The homogenates were pelleted by 
centrifugation (30000 x g for 15 min), washed 
twice (i.e., 2 cycles of suspension in 5 mM Hepes 
(pH 7.5)/l mM EGTA/250 mM sucrose/aproti- 
nin by a Teflon-pestled homogenizer followed by 
centrifugation), and finally suspended in 25 mM 
Hepes (pH 7.5)/250 mM sucrose/aprotinin. The 
concentration of aprotinin was 50 U/ml in these 
media. The suspension was then mixed with Per- 
co11 and centrifuged at 10000 x g for 20 min to ob- 
tain the plasma membrane fraction at the top of 
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Fig. 1. Enhancement by ATP of ANF-induced activation of liver membrane guanylate cyclase. (A) Time courses of 
cGMP accumulation as a result of guanylate cyclase activity in the absence (0) or presence of 1 PM ANF (A), 0.5 mM 
ATP (o), 1 pM AFN + 0.5 mM ATP (A); (B) guanylate cyclase activities plotted against increasing concentrations of 
ANF in the absence (0) or presence of 10/M (A), 30pM (o), IOOpM (A) or 3OOpM (0) ATP; (C) Lineweaver-Burk 
plots for guanylate cyclase activities as a function of GTP in the absence (0) or presence of 1 PM ANF (A), 0.5 mM 
ATP (0) or 1 ,uM ANF + 0.5 mM ATP (A). 
the centrifuge tubes. The fraction was washed and 
stored at -80°C until use. 
2.2. Assay of guanylate cyclase activity 
The thawed membrane fraction was washed in 
50 mM Tris (pH 7.5) and assayed for guanylate 
cyclase activity at 30°C in the reaction mixture 
(total volume of 0.1 ml) consisting of 50 mM Tris 
(pH 7.5), 4 mM MgC12, 10 mM theophylline, 
10 mM phosphocreatine, 100 units/ml of creatine 
phosphokinase and 1 mM GTP, unless otherwise 
specified in fig.lC. The mixture was further sup- 
plemented with ANF, the preparation (consisting 
of 3 1 amino acid residues) purified from rat atrium 
[7], and ATP used in the concentrations indicated 
in the figures. The assay was started by the addi- 
tion of the membrane fraction, continued for 
5 min except in fig. 1A and stopped by the addition 
of 0.1 ml of 0.2 N HCl followed by boiling for 
2 min. The supernatant obtained by centrifugation 
at 1500 x g for 10 min was assayed for cGMP 
generated from added GTP [8] to calculate the 
guanylate cyclase activity. Protein was determined 
by the method of Lowry et al. [9] using bovine 
serum albumin as standard. 
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2.3. lz51-ANF binding to liver plasma membranes 
Liver plasma membranes were incubated with 
0.2 nM 1251-ANF and various concentrations of 
ATP for 10 min at 20°C in the same medium as 
used for the guanylate cyclase assay. Incubation 
was terminated by the addition of 5 ml of ice-cold 
50 mM Tris (pH 7.5) containing 5 mM MgC12 and 
100 mM NaCl, and the mixture was quickly 
poured onto a glass fiber Whatman GF/C (2.4 cm 
diameter) which had been soaked in 0.1% (w/v) 
polyethyleneimine (pH 10.0) [lo]. The filter was 
rapidly rinsed twice with 5 ml of the same solution 
and then analyzed for the retained radioactivity by 
the use of a gamma counter. Specific binding 
assessed from the difference between bindings in 
the absence and presence of 1 PM non-radioactive 
ANF is shown on the ordinate. 
3. RESULTS AND DISCUSSION 
Plasma membrane rich-fractions from rat liver 
were incubated with ANF (fig.1). There was a 
slight increase in guanylate cyclase activity in 
response to ANF (fig.lA). The ANF-induced in- 
crease in guanylate cyclase activity was markedly 
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Fig.2. Guanylate cyclase activity of liver plasma membranes as supported by MgClz or MnC12. Guanylate cyclase 
activity was measured without (0) or with 1 pM ANF (A), 0.5 mM ATP (0) or 1 PM ANF + 0.5 mM ATP (A) in the 
medium containing the indicated concentrations of MgClz (A) or MnClz (B) as described in section 2. 
enhanced by ATP, though ATP by itself was 
without effect on the enzyme activity or caused 
only slight effects which were different from 
preparation to preparation (e.g., cf. fig.lC with 
fig. 1A). The guanylate cyclase activity was plotted 
against concentrations of ANF in the presence of 
Table 1 
Effects of ANF and/or ATP on guanylate cyclase 
activity in particulate or plasma membrane fractions 
prepared from various tissues and cells 
Tissues Guanylate cyclase activity 
(pmol/mg protein per min) 
None ANF ATP ANF + ATP 
Kidney 0.75 6.48 0.65 34.4 
Lung 1.36 15.91 6.85 121.6 
Heart 0.67 1.36 2.94 6.9 
Brain 1.92 4.70 3.06 12.8 
Adipocyte 1.70 18.59 4.65 118.9 
NG108-15 0.59 1.02 0.71 9.1 
Particulate fractions from kidney, lung and heart were 
prepared as described in the legend to fig.1 with the 
centrifugation step using Percoll being omitted. The 
membrane preparations from brain, adipocytes and 
NG108-15 hybrid cells were obtained by the methods of 
Katada et al. [13], Cushman and Wardzala [14] and 
Kurose et al. [15], respectively. Guanylate cyclase 
activity was then measured with 1 pM ANF and/or 
0.5 mM ATP 
ATP at concentrations from 10 to 300,~M 
(fig.lB). ATP enhanced the maximal response of 
the cyclase to ANF, without causing a significant 
change in the half-maximally effective concentra- 
tion of ANF. The cyclase activities as a function of 
the concentration of substrate, GTP, in the 
presence or absence of ANF and/or ATP are 
depicted as the Lineweaver-Burk plots in fig.lC. 
The effects of ATP and ANF were to increase the 
maximal velocity without a change in the K,,, value 
for the substrate. Thus, Max and K,,, for liver 
guanylate cyclase were 6.35 pmol/mg protein per 
min and 0.52 mM, respectively, in the absence of 
ANF and ATP. Vmax increased 2.3- (to 
14.9 pmol/mg protein per min), 3.5- (to 
22.3 pmol/mg protein per min) and 15.4- (to 
98.0 pmol/mg protein per min) fold upon the ad- 
dition of ANF, ATP and ANF + ATP, respec- 
tively. 
Crude or partially purified membrane fractions 
from various tissues and cells exhibited various 
degrees of guanylate cyclase activity (table 1). 
These guanylate cyclases were activated by ANF 
alone 2- to 12-fold, and activated 6- to go-fold by 
combining ANF with ATP, which was by itself 
essentially ineffective in some cases or activated 
the enzyme activity 1.6- to 5-fold in other cases. In 
any case, the activation of membrane guanylate 
cyclase by ANF was greater in magnitude in the 
presence of ATP than in its absence in all the 
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Table 2 
Effects of adenosine triphosphate, adenine nucleotide 
analogues and adenosine on guanylate cyclase activity in 
the presence or absence of ANF 
Additions Guanylate cyclase activity 
(pmol/mg protein per min) 
None ANF 
None 1.76 6.50 
ATP 2.03 41.43 
APPNHP 2.82 24.85 
APCHZPP 3.47 25.78 
UTP 3.43 7.33 
CTP 1.99 6.39 
ADP 1.75 18.42 
ADP,&S 2.22 11.98 
AMP 1.75 6.55 
Adenosine 2.18 7.51 
Plasma membranes partially purified from liver were 
incubated as described in the legend to fig.1 without or 
with 1 PM ANF in the presence of nucleotides or 
adenosine. The concentration of nucleotides and 
adenosine was 0.5 mM. The GTP-regenerating system 
was omitted from the assay mixture to minimize 
phosphorylation of ADP or AMP 
tissues so far studied. 
Mg2+ (or Mn2+) was essential for liver mem- 
brane guanylate cyclase; no enzymic activity was 
detected in the Mg2+- or Mn2+-free medium 
regardless of whether or not the medium was for- 
tified with ANF and/or ATP (fig.2A). The striking 
difference between MgC12 and MnC12, however, 
was found for the effect of ATP; ATP did not in- 
crease guanylate cyclase activity measured with 
MnC12 in either the presence or absence of ANF 
(fig.2B). Thus, the unique effect of ATP to poten- 
tiate ANF-induced activation of guanylate cyclase 
was not observed unless the nucleotide was added 
to the assay medium as a complex with Mg’+. 
ANF binds with a high affinity (& = 148 PM) 
to specific receptors on liver membranes as reveal- 
ed by the Scatchard analysis (not shown). Since 
essentially the same & value was obtained when 
the binding experiment was carried out in the en- 
zyme assay mixture (i.e. the medium containing 
GTP and the nucleotide-regenerating system), the 
effects of ATP on both guanylate cyclase and ‘251- 
ANF binding were then studied concurrently in 
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Fig.3. Failure of ATP to affect ‘251-ANF binding to liver 
plasma membranes. (A) Guanylate cyclase activities of 
liver plasma membranes were measured with (0) or 
without (0) 1 PM ANF in the presence of the indicated 
concentrations of ATP. (B) Binding of “‘1-ANF to liver 
plasma membranes under the same conditions. 
fig.3, in which the reaction mixture was incubated 
at 20°C with 200 pM 12’I-ANF to obtain the high- 
affinity binding of ANF. Under these conditions, 
ATP at concentrations higher than 50 PM en- 
hanced ANF-induced activation but did not alter 
the binding of ANF to membranes. Therefore, 
ATP promoted the ANF-stimulated activity by a 
different mechanism from the GTP binding pro- 
tein in the adenylate cyclase system. AppNHp, 
which does not serve as a substrate of kinases or a 
phosphate donor, enhanced ANF-induced activa- 
tion of membrane guanylate cyclase, though the 
degree of enhancement was smaller than that by 
ATP (table 2). 
The effect of ATP or ATP analogues to enhance 
guanylate cyclase activity might possibly be due to 
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inhibition of the decomposition of GTP, thereby 
supplying the enzyme with higher concentrations 
of its substrate. This possibility was studied by the 
use of [a-32P]GTP as the substrate. The concentra- 
tion of GTP after incubation was determined 
based on radioactivities in the spot of GTP after 
separation on a thin-layer plate of poly- 
ethyleneimine-cellulose. In the presence of GTP- 
regenerating agents, roughly 80% of added GTP 
remained as such after 5-min incubation of the 
cyclase assay, regardless of whether the reaction 
mixture was further supplemented with ATP (or 
ATP analogues) or not. In the absence of the 
regenerating agents, 1 mM GTP decreased to 
0.41 mM without addition of adenine nucleotides, 
to 0.55 mM with 0.5 mM ATP and to 0.75 mM 
with 0.5 mM AppNHp during 5-min incubation. 
The increase in GTP concentration from 0.4 to 
0.8 mM caused 30-40% increases in guanylate 
cyclase activity in the presence of ANF. However, 
400-600% increases in the cyclase activity were in 
fact induced by ATP or AppNHp under these con- 
ditions. Thus, the enhancing effect of ATP or 
ATP analogues on guanylate cyclase was not ac- 
counted for by the inhibition of the breakdown of 
the enzyme substrate. 
The ANF-induced activation was enhanced by 
ADP as well. ADP might be converted to ATP as 
a result of the phosphate transfer from GTP in the 
medium. But, ADPflS, which is not capable of be- 
ing phosphorylated, was still effective. Other 
nucleotide triphosphates, UTP and CTP, as well as 
adenosine and AMP did not increase guanylate 
cyclase activity in either the presence or absence of 
ANF. Thus, the effect of ATP to enhance ANF- 
induced activation of membrane guanylate cyclase 
is explainable by its allosteric effect on the enzyme 
activity rather than by the phosphorylation of 
membrane proteins. The allosteric site(s) is (are) 
rather selective to ATP but may be occupied by 
ADP or ATP- or ADP-analogues as well which 
produce smaller effects than ATP itself. A similar 
non-phosphorylating mechanism has been pro- 
posed for ATP-induced modulation of EGF recep- 
tor functions such as tyrosine kinase activity 
[11,12]. 
In conclusion, the Mg-ATP complex is a strong 
potentiator of ANF in activation of membrane 
guanylate cyclase of various membrane tissues. 
Conceivably, intracellular ATP supports the 
generation of intracellular signals upon stimula- 
tion of membrane ANF receptors. A likely 
possibility is the existence of an ATP-binding site 
on the ANF receptor-guanylate cyclase complex. 
The occupancy of this site may lead to a conforma- 
tional change of the complex, thereby facilitating 
ANF-induced activation of the catalytic activity. 
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